Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89


Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV screening working group.

Lancet. 2014 Feb 8;383(9916):524-32. doi: 10.1016/S0140-6736(13)62218-7. Epub 2013 Nov 3. Erratum in: Lancet. 2015 Oct 10;386(10002):1446.


Histological diagnosis and evaluation of the Swede score colposcopic system in a large cohort of pregnant women with atypical cervical cytology or cervical malignancy signs.

Kärrberg C, Ryd W, Strander B, Brännström M, Rådberg T.

Acta Obstet Gynecol Scand. 2012 Aug;91(8):952-8. doi: 10.1111/j.1600-0412.2012.01456.x. Epub 2012 Jun 27.


Screening and cervical cancer cure: population based cohort study.

Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S, Sparén P.

BMJ. 2012 Mar 1;344:e900. doi: 10.1136/bmj.e900.


Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.

Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.

J Clin Virol. 2012 May;54(1):61-5. doi: 10.1016/j.jcv.2012.01.012. Epub 2012 Feb 10.


Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.

Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.

J Clin Microbiol. 2011 Nov;49(11):3794-9. doi: 10.1128/JCM.00549-11. Epub 2011 Sep 21.


Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study.

Silfverdal L, Kemetli L, Sparén P, Andrae B, Strander B, Ryd W, Dillner J, Törnberg S.

Int J Cancer. 2011 Sep 15;129(6):1450-8. doi: 10.1002/ijc.25749. Epub 2010 Dec 9.


A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo.

Hovland S, Arbyn M, Lie AK, Ryd W, Borge B, Berle EJ, Skomedal H, Kadima TM, Kyembwa L, Billay EM, Mukwege D, Chirimwami RB, Mvula TM, Snijders PJ, Meijer CJ, Karlsen F.

Br J Cancer. 2010 Mar 16;102(6):957-65. doi: 10.1038/sj.bjc.6605594. Epub 2010 Mar 2.


Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.

Silfverdal L, Kemetli L, Andrae B, Sparén P, Ryd W, Dillner J, Strander B, Törnberg S.

Am J Obstet Gynecol. 2009 Aug;201(2):188.e1-7. doi: 10.1016/j.ajog.2009.04.006. Epub 2009 Jun 26.


Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.


Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T; Joint European Cohort Study.

BMJ. 2008 Oct 13;337:a1754. doi: 10.1136/bmj.a1754.


Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological follow-up.

Schledermann D, Andersen BT, Bisgaard K, Dohse M, Ejersbo D, Hoelund B, Horal P, Lindh M, Ryd W.

Diagn Cytopathol. 2008 Jul;36(7):453-9. doi: 10.1002/dc.20822.


Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.

J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.


Real-time Taqman PCR targeting 14 human papilloma virus types.

Lindh M, Görander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W.

J Clin Virol. 2007 Dec;40(4):321-4. Epub 2007 Nov 5.


Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J.

N Engl J Med. 2007 Oct 18;357(16):1589-97. Erratum in: N Engl J Med. 2008 Oct 9;359(15):1637. Johansson, Bo [added].


Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.

Strander B, Andersson-Ellström A, Milsom I, Rådberg T, Ryd W.

Cancer. 2007 Oct 25;111(5):285-91.


Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?

Strander B, Ryd W, Wallin KL, Wärleby B, Zheng B, Milsom I, Gharizadeh B, Pourmand N, Andersson-Ellström A.

Eur J Cancer. 2007 Aug;43(12):1849-55. Epub 2007 Jul 5.


HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Hansson BG, Rylander E, Dillner J.

Br J Cancer. 2007 Jul 2;97(1):129-32. Epub 2007 Jun 5.


Fine-needle aspiration cytology and core needle biopsy in the preoperative diagnosis of desmoid tumors.

Dalén BP, Meis-Kindblom JM, Sumathi VP, Ryd W, Kindblom LG.

Acta Orthop. 2006 Dec;77(6):926-31.


Abnormal fatty acid pattern in intestinal mucosa of children with celiac disease is not reflected in serum phospholipids.

Steel DM, Ryd W, Ascher H, Strandvik B.

J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):318-23.


Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

Elfgren K, Rylander E, Rådberg T, Strander B, Strand A, Paajanen K, Sjöberg I, Ryd W, Silins I, Dillner J; Swedescreen Study Group.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):650-7.


Supplemental Content

Loading ...
Support Center